Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile
- Supplementary File 1:
PDF-Document (PDF, 683 KiB)
Canale, V.; Rak, A.; Kotańska, M.; Knutelska, J.; Siwek, A.; Bednarski, M.; Nowiński, L.; Zygmunt, M.; Koczurkiewicz, P.; Pękala, E.; Sapa, J.; Zajdel, P. Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile. Molecules 2018, 23, 2175. https://doi.org/10.3390/molecules23092175
Canale V, Rak A, Kotańska M, Knutelska J, Siwek A, Bednarski M, Nowiński L, Zygmunt M, Koczurkiewicz P, Pękala E, Sapa J, Zajdel P. Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile. Molecules. 2018; 23(9):2175. https://doi.org/10.3390/molecules23092175
Chicago/Turabian StyleCanale, Vittorio, Aleksandra Rak, Magdalena Kotańska, Joanna Knutelska, Agata Siwek, Marek Bednarski, Leszek Nowiński, Małgorzata Zygmunt, Paulina Koczurkiewicz, Elżbieta Pękala, Jacek Sapa, and Paweł Zajdel. 2018. "Synthesis and Pharmacological Evaluation of Novel Silodosin-Based Arylsulfonamide Derivatives as α1A/α1D-Adrenergic Receptor Antagonist with Potential Uroselective Profile" Molecules 23, no. 9: 2175. https://doi.org/10.3390/molecules23092175